e-ISSN: Pending
Negative / Null Result ReportOpen accessBiochemistry, Genetics and Molecular Biology· cited by 11

Gut microbiome and its metabolites in liver cirrhosis: mechanisms and clinical implications

Luyuan Chang; Yang Liu; Haipeng Li; Jiaqi Yan; Wei Wu; Nuo Chen; Chunyu Ma; Xinyi Zhao · 2025 · Frontiers in Cellular and Infection Microbiology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Cirrhosis remains a significant global health burden, causing approximately 1.4-1.5 million deaths each year and contributing to nearly 46 million disability-adjusted life years (DALYs) worldwide. Increasing evidence identifies the gut-liver axis as a central driver of disease progression, wherein intestinal dysbiosis, barrier disruption, and microbe-derived metabolites collectively exacerbate inflammation, fibrogenesis, and related complications. Across more than 40 recent studies, gut microbial α-diversity declined by 30-60%, and over 80% reported a marked depletion of short-chain fatty acid

Abstract by Luyuan Chang; Yang Liu; Haipeng Li; Jiaqi Yan; Wei Wu; Nuo Chen; Chunyu Ma; Xinyi Zhao, Frontiers in Cellular and Infection Microbiology (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3389/fcimb.2025.1717696